GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth
GrB-Fc-KS49 是一种抗 EMP2 颗粒酶 B 融合蛋白疗法,它能改变免疫细胞浸润并抑制乳腺癌生长。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-008891
Mohamedali, Khalid A; Aguirre, Brian; Lu, Cheng-Hsiang; Chandla, Anubhav; Kejriwal, Nidhi; Liu, Lucia; Chan, Ann M; Cheung, Lawrence H; Kok, SuYin; Duarte, Sergio; Alvarez de Cienfuegos, Ana; Casero, David; Rosenblum, Michael G; Wadehra, Madhuri